Desirudin reduces the rate of microvenous thrombosis in a rat model

Laryngoscope

Volumn 118, Issue 7, 2008, Pages 1149-1152

  Lewis, Carol M ^a,b   Deschler, Daniel G ^a,b,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Triological Society Eastern Section Meeting   (United States)

^c MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

Author keywords

Desirudin; Free flap; Microvascular; Thrombosis

Indexed keywords

DESULFATOHIRUDIN; PLACEBO; SODIUM CHLORIDE; FIBRINOLYTIC AGENT; HIRUDIN DERIVATIVE; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLEEDING TIME; BLOOD CLOT; CONTROLLED STUDY; DRUG EFFICACY; FEMORAL VEIN; FREE TISSUE GRAFT; IN VIVO STUDY; MALE; MICROVASCULATURE; MICROVENOUS THROMBOSIS; NONHUMAN; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RAT; THROMBOGENICITY; TREATMENT DURATION; VASCULAR PATENCY; VEIN ANASTOMOSIS; VEIN THROMBOSIS; ANASTOMOSIS; ANIMAL; DISEASE MODEL; DRUG EFFECT; GRAFT SURVIVAL; MICROCIRCULATION; MICROSURGERY; PLASTIC SURGERY; PREOPERATIVE CARE; SPRAGUE DAWLEY RAT; THROMBOSIS; VASCULARIZATION;

ANASTOMOSIS, SURGICAL; ANIMALS; DISEASE MODELS, ANIMAL; FIBRINOLYTIC AGENTS; GRAFT SURVIVAL; HIRUDINS; MALE; MICROCIRCULATION; MICROSURGERY; PREOPERATIVE CARE; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; SURGICAL FLAPS; THROMBOSIS;

EID: 47149110007     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MLG.0b013e31816d727c     Document Type: Article

References (22)

1. Nakatsuka T, Harii K, Asato H, et al. Analytic review of 2372 free flap transfers for head and neck reconstruction following cancer resection. J Reconstr Microsurg 2003;19: 363-368.
2. Chien W, Varvares MA, Hadlock T, Cheney M, Deschler DG. Effects of aspirin and low-dose heparin in head and neck reconstruction using microvascular free flaps. Laryngoscope 2005;115:973-976.
3. Bui DT, Cordiero PG, Hu QY, Disa JJ, Pusic A, Mehrara BJ. Free flap reexploration: indications, treatment, and outcomes in 1193 free flaps. Plast Reconstr Surg 2007;119: 2092-2100.
4. Blackwell KE, Brown MT, Gonzalez D. Overcoming the learning curve in microvascular head and neck reconstruction. Arch Otolaryngol Head Neck Surg 1997;123:1332-1335.
5. Peter FW, Franken RJ, Wang WZ, et al. Effect of low dose aspirin on thrombus formation at arterial and venous microanastomoses and on the tissue microcirculation. Plast Reconstr Surg 1997;99:1112-1121.
6. Hadlock TA, Kim J, Deschler DG. The effect of subcutaneously administered low-molecular-weight heparin on microarterial thrombosis in the rat. Arch Facial Plast Surg 2003;5:36-39.
7. Murthy P, Riesberg MV, Hart S, et al. Efficacy of perioperative thromboprophylactic agents in the maintenance of anastomotic patency and survival of rat microvascular free groin flaps. Otolaryngol Head Neck Surg 2003;129:176-182.
8. Emerick KS, Deschler DG. The effect of low-molecular-weight heparin on microvenous thrombosis in a rat model. Arch Facial Plast Surg 2007;9:19-21.
9. Nayak VK, Deschler DG. Clodipogrel use for reducing the rate of thrombosis in a rat model of microarterial anastomosis. Arch Otolaryngol Head Neck Surg 2005;131:800-803.
10. Bernat A, Mares AM, Defreyn G, Maffrand JP, Herbert JM. Effect of various antiplatelet agents on acute arterial thrombosis in the rat. Thromb Haemost 1993;70:812-816.
11. Moore MG, Deschler DG. Clopidogrel (plavix) reduces the rate of thrombosis in the rat tuck model for microvenous anastomosis. Otolaryngol Head Neck Surg 2007;136:573-576.
12. Snyderman CH. The pathogenesis of vascular thrombosis and its impact in microvascular surgery. Head Neck 1999;21:355-362.
13. Di Nisio M, Middeldorp S, Buller HR. Direct thrombin inhibitors. N Engl J Med 2005;353:1028-1040.
14. Eriksson BI, Wille-Jorgensen P, Kalebo P, et al. A comparison of recombinant hirudin with low-molecular-weight heparin to prevent thromboembolic complications after total hip replacement. N Engl J Med 1997;337:1329-1335.
15. White H. Hirulog and Early Reperfusion or Occlusion (HERO) -2 Trial Investigators. Thrombin-specific anticoagulation with bivalrudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction: the HERO-2 randomised trial. Lancet 2001;358:1855-1863.
16. Arnljots B, Bergqvist D. Inhibition of heparin-resistant microarterial thrombosis by recombinant hirudin: a specific thrombin inhibitor. Plast Reconstr Surg 1995;95:894-900.
17. Meyer BJ, Badimon JJ, Chesebro JH, Fallon JT, Fuster V, Badimon L. Dissolution of mural thrombus by specific thrombin inhibition with r-hirudin: comparison with heparin and aspirin. Circulation 1998;97:681-685.
18. Stepnick D, Hayden R, Hogikyan N. Development of thrombosis models in the rabbit. Arch Otolaryngol Head Neck Surg 1994;120:997-1002.
19. Dejana E, Villa S, Gaetano G. Bleeding time in rats: a comparison of different experimental conditions. Thromb Haemost 1982;48:108-111.
20. Spiegal JH, Polat JK. Microvascular flap reconstruction by otolaryngologists: prevalence, postoperative care, and monitoring techniques. Laryngoscope 2007;117:485-490.
21. Girolami B, Girolami A. Heparin-induced thrombocytopenia: a review. Semin Thromb Hemost 2006;32:803-809.
22. Greinacher A, Eichler P, Albrecht D, Strobel U, Potzsch B, Eriksson BI. Antihirudin antibodies following low-dose subcutaneous treatment with desirudin for thrombosis prophylaxis after hip-replacement surgery: incidence and clinical relevance. Blood 2003;101:2617-2619.